Two Indian pharmaceutical companies, Cipla Ltd. and Ranbaxy Laboratories Ltd., have agreed to cut the price of 19 AIDS meds by 45% to make them more accessible to children worldwide. The deal makes treatment available early next year for over 10,000 HIV positive kids in India.